18
Participants
Start Date
December 22, 2016
Primary Completion Date
June 29, 2023
Study Completion Date
June 29, 2023
metronomic therapy
"* Propranolol 0.5 mg/kgxd p.o. day 1,~ 1. mg/kgxd p.o. day 2,~ 2. mg/kgxd p.o. day 3-365 (maximum total daily dose: 120 mg) divided in 2 doses per day~* Celecoxib 400 mg/m2xd p.o.; day 1-365 (maximum total daily dose: 800 mg) divided in 2 doses per day~* Cyclophosphamide cycle 1, day1: loading dose: 500 mg/m2 intravenous 1-h-infusion, single dose day 2-365 25 mg/m2xd p.o (maximum total daily dose: 50 mg) as single daily dose~* Vinblastine 3 mg/m2xd i.v. (maximum total daily dose: 6 mg) administered day 1 and 15 (every two weeks) as single daily dose~* Etoposide 25 mg/m2xd p.o.; day 1-21 weeks 1-3, 9-11, 17-19, 25-27 (maximum total daily dose: 50 mg) as single daily dose"
Marc Hoemberg, Cologne
Children's University Hospital, Bonn
Children's University Hospital, Essen
Children's University Hospital, Frankfurt
Children's University Hospital, Freiburg im Breisgau
Children's Hospital, Medizinische Hochschule, Hanover
Children's University Hospital, Leipzig
Dr. von Haunersches Kinderspital, München
University of Cologne
OTHER